These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33218982)

  • 1. Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910-1919.
    Larroumet A; Foussard N; Monlun M; Blanco L; Mohammedi K; Rigalleau V
    Diabetes Care; 2020 Dec; 43(12):e198. PubMed ID: 33218982
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910-1919.
    Pantalone KM; Misra-Hebert AD; Burguera B; Kattan MW
    Diabetes Care; 2020 Dec; 43(12):e199. PubMed ID: 33218983
    [No Abstract]   [Full Text] [Related]  

  • 3. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model.
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Kong SX; Ji X; Ganguly R; Milinovich A; Weng W; Bauman JM; Petraro P; Burguera B; Zimmerman RS; Kattan MW
    Diabetes Care; 2020 Aug; 43(8):1910-1919. PubMed ID: 32527797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
    Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
    Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes.
    Yeh A; Shah-Manek B; Lor KB
    Ann Pharmacother; 2017 Feb; 51(2):111-117. PubMed ID: 28042735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes managment: Beyond hemoglobin A
    Makin V; Lansang MC
    Cleve Clin J Med; 2019 Sep; 86(9):595-600. PubMed ID: 31498766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement.
    Leiter LA; Cheng AYY; Ekoé JM; Goldenberg RM; Harris SB; Hramiak IM; Khunti K; Lin PJ; Richard JF; Senior PA; Yale JF; Goldin L; Tan MK; Langer A
    Can J Diabetes; 2019 Aug; 43(6):384-391. PubMed ID: 30554985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials.
    Blonde L; Woo V; Mathieu C; Yee J; Vijapurkar U; Canovatchel W; Meininger G
    Curr Med Res Opin; 2015 Nov; 31(11):1993-2000. PubMed ID: 26373629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ABC (HbA1c, blood pressure, LDL-cholesterol) goal attainment with depression and health-related quality of life among adults with type 2 diabetes.
    Shah BM; Mezzio DJ; Ho J; Ip EJ
    J Diabetes Complications; 2015 Aug; 29(6):794-800. PubMed ID: 25976863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes.
    Nichols GA; Kimes TM; Harp JB; Kou TD; Brodovicz KG
    Diabetes Care; 2012 Mar; 35(3):495-7. PubMed ID: 22279033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.
    Bergenstal RM; Beck RW; Close KL; Grunberger G; Sacks DB; Kowalski A; Brown AS; Heinemann L; Aleppo G; Ryan DB; Riddlesworth TD; Cefalu WT
    Diabetes Care; 2019 Feb; 42(2):e29-e30. PubMed ID: 30559104
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of frail or dependent elderly patients with type 2 diabetes].
    Verny C; Noaillon M; Baudry É
    Rev Prat; 2015 Oct; 65(8):1046-9. PubMed ID: 26749703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care delivery in youth with type 2 diabetes - are we meeting clinical practice guidelines?
    Amed S; Nuernberger K; Reimer K; Krueger H; Aydede SK; Ayers D; Collet JP
    Pediatr Diabetes; 2014 Nov; 15(7):477-83. PubMed ID: 24888460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: Pantalone et al. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes Care 2010;33:1224-1229.
    Khalangot MD
    Diabetes Care; 2011 Aug; 34(8):e138; author reply 139. PubMed ID: 21788641
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality measure attainment in patients with type 2 diabetes mellitus.
    Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P
    Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin A1c outcomes and health care resource use in type 2 diabetes mellitus patients treated with combination oral antidiabetic drugs through step therapy and loose-dose and fixed-dose combinations.
    Williams SA; Buysman EK; Hulbert EM; Bergeson JG; Zhang B; Graham J
    Manag Care; 2012 Jul; 21(7):40-8. PubMed ID: 22876522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment goals in diabetes type].
    Lilja M; Hellgren M; Jansson S
    Lakartidningen; 2018 Feb; 115():. PubMed ID: 29461567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.
    Pluchino KM; Wu Y; Silk AD; Yi J; Lias CH
    Diabetes Care; 2019 Feb; 42(2):e28. PubMed ID: 30559103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.